Emetest Advanced Blood Glucose/Cholesterol/Uric Acid/Heme/Triglycerides Monitoring System - Taiwan Registration 7dec9ae6d337cf10b5d5587f9e567f06
Access comprehensive regulatory information for Emetest Advanced Blood Glucose/Cholesterol/Uric Acid/Heme/Triglycerides Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7dec9ae6d337cf10b5d5587f9e567f06 and manufactured by BIOPTIK TECHNOLOGY, INC.. The authorized representative in Taiwan is BIOPTIK TECHNOLOGY, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is for in vitro testing only, measured with fresh fingertip microvascular whole blood to quantify blood glucose, cholesterol, uric acid, heme and triglycerides. This product can be used by self-testing and healthcare professionals, but is not intended for testing of newborns.
A Clinical chemistry and clinical toxicology
A.1775 Uric acid testing system;; A.1345 Glucose Test System;; A.1705 Triglyceride Test System
ๅ็ข;; QMS/QSD
Dates and Status
Mar 15, 2021
Mar 15, 2026